Bonus Episode: ALK Positive Charity Short Series - Dr. Shobhit Baijal Consultant Medical Oncologist

Trigger Warning: this episode discusses cancer, cancer treatment, lung cancer and medications.Bonus Episode in collaboration with ALK+ charity.Description: In this powerful episode, Naman Julka-Anderson and Jo McNamara sit down with Dr. Shobhit Baijal.Dr. Shobhit Baijal is a leading Consultant Medical Oncologist at The University Hospitals Birmingham NHS Trust and an Honorary Associate Professor at The University of Birmingham. He is a renowned expert in the Oncological management of all forms of Lung, Colorectal and Liver malignancies.Dr. Baijal completed his medical training at St Bartholomew's Medical School, including a First Class BSc Honours in immunology and cell pathology from University College London. He went on to specialise in Medical Oncology in the West Midlands and was appointed Consultant to University Hospitals Birmingham NHS Trust in 2011.Dr. Baijal actively treat lung, colorectal and liver cancer across multiple hospital sites within the West Midlands. He specialises in all forms of cancer drug treatments including chemotherapy, immuno-oncology, precision oncology and chemoembolisation.He has a large Clinical Trial portfolio and is the UK Chief and Principle Investigator for National and International studies. He works closely with Pharmaceutical companies to access novel drugs for his patients. Dr. Baijal has published extensively and regularly presents at regional, national and international cancer meetings. He is an invited Medical Expert for NICE committee reviews for new anti-cancer drug therapies.As a Steering Committee member of the British Thoracic Oncology Group he has a pivotal role in supporting and educating Thoracic Oncology professionals across the United Kingdom. He is an Honorary Clinical Advisor for EGFR positive UK, on the Expert Panel for Roy Castle Foundation and is also an advisor to ALK Positive UK.This episode is a deep dive into Shobhit’s career, ALK+ lung cancer and it’s treatment along with how you can support the ALK+ charity.CPD Reflection Points:Read about ALK+ cancer.Read about the treatment options for ALK+ cancer.Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:Roy Castle FoundationEGFR positive UKBritish Thoracic Oncology GroupResearch links from the Episode:ALEX StudyFirst targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICERad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.